[go: up one dir, main page]

EE200300371A - Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid - Google Patents

Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid

Info

Publication number
EE200300371A
EE200300371A EEP200300371A EEP200300371A EE200300371A EE 200300371 A EE200300371 A EE 200300371A EE P200300371 A EEP200300371 A EE P200300371A EE P200300371 A EEP200300371 A EE P200300371A EE 200300371 A EE200300371 A EE 200300371A
Authority
EE
Estonia
Prior art keywords
formulations
oral
pharmaceutical
topical administration
topical
Prior art date
Application number
EEP200300371A
Other languages
English (en)
Inventor
Andrysek Tomas
Stuchlik Milan
Vrana Ales
Jegorov Alexandr
Stuchlik Josef
Matha Vladimir
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300371(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galena As filed Critical Galena As
Publication of EE200300371A publication Critical patent/EE200300371A/et
Publication of EE04955B1 publication Critical patent/EE04955B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
EEP200300371A 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm EE04955B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
EEP200200075A EE04954B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Publications (2)

Publication Number Publication Date
EE200300371A true EE200300371A (et) 2003-10-15
EE04955B1 EE04955B1 (et) 2008-02-15

Family

ID=10859192

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200300371A EE04955B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
EEP200200075A EE04954B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm

Family Applications After (1)

Application Number Title Priority Date Filing Date
EEP200200075A EE04954B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm

Country Status (40)

Country Link
US (1) US20070190132A1 (et)
EP (2) EP1334717B1 (et)
JP (2) JP2003507343A (et)
KR (2) KR100828748B1 (et)
CN (2) CN1382061A (et)
AR (2) AR025324A1 (et)
AT (2) ATE402691T1 (et)
AU (1) AU777740B2 (et)
BR (1) BR0013385A (et)
CA (2) CA2380951C (et)
CO (1) CO5380014A1 (et)
CY (1) CY1105318T1 (et)
CZ (2) CZ296591B6 (et)
DE (2) DE60018081T2 (et)
DK (2) DK1210119T3 (et)
EE (2) EE04955B1 (et)
EG (1) EG23994A (et)
ES (2) ES2237443T3 (et)
GB (1) GB2355656B (et)
HK (1) HK1049629A1 (et)
HR (1) HRP20020154B1 (et)
HU (1) HUP0203236A3 (et)
IL (4) IL148200A0 (et)
JO (1) JO2324B1 (et)
MX (1) MXPA02001631A (et)
NO (2) NO20020760L (et)
NZ (1) NZ517271A (et)
PE (1) PE20010636A1 (et)
PL (1) PL192769B1 (et)
PT (2) PT1210119E (et)
RU (2) RU2279894C2 (et)
SA (1) SA00210487B1 (et)
SG (1) SG143019A1 (et)
SI (1) SI1210119T1 (et)
SK (2) SK286083B6 (et)
TN (1) TNSN00173A1 (et)
UA (2) UA72539C2 (et)
UY (1) UY26303A1 (et)
WO (1) WO2001012229A1 (et)
ZA (2) ZA200308221B (et)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
CN100337620C (zh) * 2002-12-04 2007-09-19 日清药业股份有限公司 含有辅酶q10的水溶性组合物
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
KR20200083657A (ko) * 2002-12-09 2020-07-08 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
EP1806125B1 (en) * 2004-10-20 2011-08-03 Kao Corporation Liquid compositions for oral cavity
KR20080003322A (ko) * 2005-02-24 2008-01-07 엘란 파마 인터내셔널 리미티드 도세탁셀 및 이의 유사체의 나노입자 배합물
WO2010060798A1 (en) * 2008-11-28 2010-06-03 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
BRPI1008983A2 (pt) * 2009-03-12 2016-03-22 Advance Holdings Ltd formulação farmacêutica
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
EP3274054A1 (en) 2015-03-27 2018-01-31 Arch Personal Care Products, L.P. Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
US20250186542A1 (en) * 2022-05-02 2025-06-12 Chugai Seiyaku Kabushiki Kaisha Composition containing peptide compound for use with surfactant
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ267796A3 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
EP0973502A1 (en) * 1997-03-12 2000-01-26 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
DK0969856T3 (da) * 1997-03-12 2005-05-02 Abbott Lab Hydrofile, binære systemer til administrering af cyclosporin
AU728698B2 (en) * 1997-07-29 2001-01-18 Boehringer Ingelheim International Gmbh Self-emulsifying formulation for lipophilic compounds
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
IL148200A0 (en) 2002-09-12
DE60322454D1 (de) 2008-09-11
IL148200A (en) 2007-12-03
AR025324A1 (es) 2002-11-20
ZA200201315B (en) 2004-06-30
CZ2002575A3 (cs) 2003-05-14
PT1334717E (pt) 2008-10-09
SA00210487B1 (ar) 2006-09-10
GB9919288D0 (en) 1999-10-20
BR0013385A (pt) 2002-05-07
CA2380951A1 (en) 2001-02-22
ATE288766T1 (de) 2005-02-15
EP1210119A1 (en) 2002-06-05
RU2279894C2 (ru) 2006-07-20
JO2324B1 (en) 2005-09-12
DE60018081D1 (de) 2005-03-17
HK1049629A1 (zh) 2003-05-23
CN101406453A (zh) 2009-04-15
EG23994A (en) 2008-03-10
HRP20020154B1 (en) 2006-07-31
CA2380951C (en) 2010-03-23
UY26303A1 (es) 2001-03-16
MXPA02001631A (es) 2003-07-14
DK1334717T3 (da) 2008-11-24
EE04954B1 (et) 2008-02-15
IL158108A (en) 2010-04-15
NO20020760L (no) 2002-04-16
PT1210119E (pt) 2005-05-31
AU777740B2 (en) 2004-10-28
SK286083B6 (sk) 2008-03-05
UA72539C2 (en) 2005-03-15
SI1210119T1 (en) 2005-06-30
CZ296170B6 (cs) 2006-01-11
SK2482002A3 (en) 2002-12-03
US20070190132A1 (en) 2007-08-16
NO20034778L (no) 2002-04-16
JP2003507343A (ja) 2003-02-25
EP1334717A3 (en) 2004-01-02
EE04955B1 (et) 2008-02-15
EE200200075A (et) 2003-04-15
NO20020760D0 (no) 2002-02-15
DE60018081T2 (de) 2006-01-05
PL192769B1 (pl) 2006-12-29
JP2004238399A (ja) 2004-08-26
DK1210119T3 (da) 2005-06-20
KR20020059367A (ko) 2002-07-12
GB2355656A (en) 2001-05-02
KR100828747B1 (ko) 2008-05-09
SG143019A1 (en) 2008-06-27
TNSN00173A1 (en) 2005-11-10
UA75926C2 (en) 2006-06-15
PE20010636A1 (es) 2001-06-02
AU6461300A (en) 2001-03-13
ATE402691T1 (de) 2008-08-15
EP1210119B1 (en) 2005-02-09
CZ296591B6 (cs) 2006-04-12
ES2311077T3 (es) 2009-02-01
ZA200308221B (en) 2004-09-29
NO20034778D0 (no) 2003-10-24
ES2237443T3 (es) 2005-08-01
RU2279895C2 (ru) 2006-07-20
HUP0203236A3 (en) 2004-06-28
CA2452118A1 (en) 2001-02-22
PL353445A1 (en) 2003-11-17
RU2003133451A (ru) 2005-04-20
EP1334717A2 (en) 2003-08-13
CN1382061A (zh) 2002-11-27
HRP20020154A2 (en) 2003-12-31
CY1105318T1 (el) 2010-03-03
WO2001012229A1 (en) 2001-02-22
KR20050095651A (ko) 2005-09-29
IL158108A0 (en) 2004-03-28
HUP0203236A2 (hu) 2003-01-28
GB2355656B (en) 2004-04-07
AR043106A2 (es) 2005-07-20
CO5380014A1 (es) 2004-03-31
KR100828748B1 (ko) 2008-05-09
EP1334717B1 (en) 2008-07-30
NZ517271A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
NO20003218L (no) Oral farmasøytisk doseringsform med forlenget frigivningsvirkning
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO20014035D0 (no) System for oral administrasjon av medikament
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
NO20002526L (no) Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
GB9902227D0 (en) Pharmaceutical composition for topical administration
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration
AR018092A1 (es) Composicion farmaceutica liquida para administracion oral
FI964663A0 (fi) Farmaceutisk analgetisk komposition foer lokal administrering
EE200200229A (et) Diarüülenüünid, kompositsioon ja farmatseutiline kompositsioon

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100817